The Procter & Gamble Company (PG) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 27	$1.41	$1.43	+1.4%	—	—	—
Q4 26	$1.56	$1.59	+1.9%	—	—	—
Q3 26	$1.86	$1.88	+1.1%	—	—	—
Q2 26	$1.9	$1.99	+4.7%	—	—	—
Q1 26	$1.42	$1.48	+4.2%	—	—	—
Q4 25	$1.53	$1.54	+0.7%	—	—	—
Q3 25	$1.86	$1.88	+1.1%	—	—	—
Q2 25	$1.9	$1.93	+1.6%	—	—	—
Q1 25	$1.37	$1.4	+2.2%	—	—	—
Q4 24	$1.41	$1.52	+7.8%	—	—	—
Q3 24	$1.7	$1.84	+8.2%	—	—	—
Q2 24	$1.72	$1.83	+6.4%	—	—	—
Q1 24	$1.32	$1.37	+3.8%	—	—	—
Q4 23	$1.32	$1.37	+3.8%	—	—	—
Q3 23	$1.59	$1.59	0.0%	—	—	—
Q2 23	$1.55	$1.57	+1.3%	—	—	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$6.75	—	—	$87B	—
FY25	—	$6.67	—	—	$84.3B	—
FY24	—	$6.18	—	—	$84B	—
FY23	—	$6.07	—	—	$82B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$65.1B	$66.8B	$67.7B	$71B	$76.1B	$80.2B	$82B	$84B	$84.3B	$87B
YoY change	-0.37%	+2.73%	+1.27%	+4.83%	+7.28%	+5.35%	+2.27%	+2.48%	+0.29%	+3.26%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	65.1B	66.8B	67.7B	71B	76.1B	80.2B	82B	84B	84.3B	87B
Cost of revenue	32.6B	34.4B	34.8B	35.3B	37.1B	42.2B	42.8B	40.8B	41.2B	43.4B
Gross profit	32.4B	32.4B	32.9B	35.7B	39B	38B	39.2B	43.2B	43.1B	43.7B
Gross margin	49.8%	48.5%	48.6%	50.3%	51.2%	47.4%	47.9%	51.4%	51.2%	50.2%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	18.7B	19B	19.1B	20B	21B	20.2B	21.1B	23.3B	22.7B	23.9B
Operating expenses	18.7B	19B	19.1B	20B	21B	20.2B	21.1B	23.3B	22.7B	23.9B
Operating income	13.8B	13.4B	13.8B	15.7B	18B	17.8B	18.1B	19.9B	20.5B	19.7B
Operating margin	21.2%	20%	20.4%	22.1%	23.6%	22.2%	22.1%	23.7%	24.3%	22.7%
Non-operating income, net	-215M	222M	-7.5B	438M	86M	570M	668M	-673M	154M	1.1B
Pretax income	13.3B	13.3B	6.1B	15.8B	17.6B	18B	18.4B	18.8B	20.2B	20.4B
Income tax	3.1B	3.5B	2.1B	2.7B	3.3B	3.2B	3.6B	3.8B	4.1B	4.2B
Net income	15.4B	9.9B	4B	13.1B	14.4B	14.8B	14.7B	15B	16.1B	16.1B
Net margin	23.7%	14.8%	5.86%	18.5%	18.9%	18.4%	18%	17.8%	19.1%	18.5%
EBITDA	16.5B	16.7B	17.7B	19.3B	20.9B	21.2B	21.8B	23.9B	23.9B	24.4B
EPS	5.8	3.75	1.45	5.13	5.69	6	6.07	6.18	6.67	6.75
Diluted EPS	5.59	3.67	1.43	4.96	5.5	5.81	5.9	6.02	6.51	6.62

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	21.9B	21.4B	20.2B	20.5B	21.7B	21.9B	19.8B	20.9B	22.4B	22.2B	21.2B	21.2B
Cost of revenue	10.5B	10.1B	9.9B	10.3B	10.4B	10.4B	9.7B	10.6B	10.9B	10.8B	10.7B	10.9B
Gross profit	11.4B	11.3B	10.3B	10.2B	11.3B	11.5B	10.1B	10.3B	11.5B	11.4B	10.5B	10.3B
Gross margin	52%	52.7%	51.2%	49.6%	52.1%	52.4%	51%	49.1%	51.4%	51.2%	49.5%	48.5%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	5.6B	5.5B	5.9B	6.3B	5.5B	5.7B	5.5B	5.9B	5.6B	6B	5.9B	6.3B
Operating expenses	5.6B	5.5B	5.9B	6.3B	5.5B	5.7B	5.5B	5.9B	5.6B	6B	5.9B	6.3B
Operating income	5.8B	5.8B	4.5B	3.9B	5.8B	5.7B	4.6B	4.4B	5.9B	5.4B	4.6B	4B
Operating margin	26.4%	26.9%	22.1%	18.9%	26.7%	26.2%	23%	20.8%	26.2%	24.2%	21.6%	18.6%
Non-operating income, net	132M	-1.2B	260M	98M	-554M	224M	210M	274M	268M	160M	537M	112M
Pretax income	5.8B	4.5B	4.6B	3.9B	5.1B	5.8B	4.7B	4.5B	6B	5.4B	5B	3.9B
Income tax	1.2B	1B	812M	726M	1.2B	1.2B	868M	895M	1.3B	1.1B	1B	852M
Net income	4.6B	3.5B	3.8B	3.1B	4B	4.7B	3.8B	3.6B	4.8B	4.3B	4B	3.1B
Net margin	20.8%	16.3%	18.7%	15.3%	18.3%	21.3%	19.2%	17.4%	21.4%	19.5%	18.6%	14.5%
EBITDA	6.7B	6.8B	5.5B	4.9B	6.1B	6.8B	5.6B	5.5B	7B	6.4B	6B	5B
EPS	1.89	1.44	1.56	1.3	1.65	1.94	1.58	1.51	2	1.82	1.66	1.28
Diluted EPS	1.83	1.4	1.52	1.27	1.61	1.88	1.54	1.48	1.95	1.78	1.63	1.26

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	230.3B	197.4B	294.7B	303.6B	339.2B	353.3B	359.4B	397.1B	381.6B	342.2B	346.1B
Enterprise value	246.7B	216.9B	314.5B	323.1B	361.8B	378.4B	386.5B	420.9B	407.5B	367.3B	366B
Shares outstanding	2.6B	2.5B	2.7B	2.5B	2.5B	2.5B	2.4B	2.4B	2.4B	2.3B	2.3B

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	14.9	20	74.3	23.2	23.6	23.9	24.4	26.5	23.8	21.2	22.1
P/S	3.54	2.95	4.35	4.28	4.46	4.41	4.38	4.72	4.53	3.93	3.9
P/B	4.13	3.73	6.19	6.48	7.27	7.54	7.64	7.85	7.3	6.3	6.37
EV/EBITDA	14.9	13	17.7	16.7	17.4	17.8	17.7	17.6	17	15	14.8
EV/Sales	3.79	3.25	4.65	4.55	4.75	4.72	4.71	5.01	4.83	4.22	4.21
Earnings yield	6.69%	4.99%	1.35%	4.32%	4.23%	4.19%	4.1%	3.77%	4.21%	4.72%	4.53%
FCF yield	4.07%	5.65%	4.04%	4.72%	4.59%	3.84%	3.84%	4.16%	3.68%	4.43%	3.84%
PEG	—	—	—	—	—	—	—	—	—	—	-1.45

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	49.8%	48.5%	48.6%	50.3%	51.2%	47.4%	47.9%	51.4%	51.2%	50.2%	48.5%
Operating margin	21.2%	20%	20.4%	22.1%	23.6%	22.2%	22.1%	23.7%	24.3%	22.7%	22.1%
Net margin	23.7%	14.8%	5.86%	18.5%	18.9%	18.4%	18%	17.8%	19.1%	18.5%	18.4%
ROE	27.6%	18.6%	8.34%	28%	30.8%	31.6%	31.3%	29.6%	30.7%	29.7%	30.3%
ROA	12.8%	8.33%	3.45%	10.9%	12%	12.6%	12.2%	12.2%	12.8%	12.8%	10.7%
ROIC	14.7%	13.7%	13.4%	19.6%	21.2%	20.4%	19.6%	21.3%	20.8%	19.7%	19.7%
Return on tangible assets	-88.7%	-49.7%	-28.6%	-196%	-146.1%	-154.9%	-183%	-642.4%	-850%	1.5K%	1.5K%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	0.88	0.83	0.75	0.85	0.7	0.65	0.63	0.73	0.7	0.68	0.68
Quick ratio	0.72	0.66	0.58	0.68	0.52	0.45	0.44	0.53	0.49	0.47	0.47
Debt / equity	0.57	0.59	0.63	0.76	0.7	0.69	0.75	0.66	0.68	0.64	0.64
Debt / assets	0.26	0.26	0.26	0.3	0.28	0.28	0.29	0.27	0.28	0.28	0.28
Net debt / EBITDA	0.99	1.17	1.12	1.01	1.08	1.18	1.25	1	1.08	1.03	1.03
Interest coverage	29.5	27.3	12.9	35.1	36.1	42	25.3	21.3	23.2	24.2	24.3
Effective tax rate	23.1%	26%	34.7%	17.2%	18.5%	17.8%	19.7%	20.2%	20.3%	20.8%	20.8%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	24.6	26.4	25.2	27.9	30.3	32.6	34.6	34.9	35.2	37.3	37.3
EPS (basic)	5.8	3.75	1.45	5.13	5.69	6	6.07	6.18	6.67	6.75	6.75
EPS (diluted)	5.59	3.67	1.43	4.96	5.5	5.81	5.9	6.02	6.51	6.62	6.62
Book value per share	21.1	20.9	17.7	18.5	18.6	19.1	19.9	21	21.8	23.3	22.9
FCF per share	3.55	4.41	4.43	5.64	6.2	5.52	5.82	6.86	5.86	6.49	6.28
Cash per share	5.73	4.69	3.83	6.37	4.09	2.94	3.48	3.94	3.99	4.26	4.28
Capex per share	—	—	—	—	—	—	—	—	—	1.89	1.83

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	—	—	—	—	—	—	—	—	—	5.07%	5.07%
Capex / operating cash flow	—	—	—	—	—	—	—	—	—	22.5%	22.5%
Payout ratio	47%	74.1%	189.1%	59.4%	57.6%	59.3%	61.1%	62.2%	61.5%	63.4%	64.3%
Dividend yield	3.14%	3.7%	2.54%	2.57%	2.44%	2.48%	2.5%	2.35%	2.59%	2.99%	2.92%

Yield

2.92%

trailing twelve months

Frequency

Quarterly

Last dividend

$1.089

ex-dividend Jul 24, 2026

Payout ratio

64%

of earnings

Dividend growth

13 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jul 24, 2026	$1.089
Apr 24, 2026	$1.089
Jan 23, 2026	$1.057

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	$21.9B	$21.4B	$20.2B	$20.5B	$21.7B	$21.9B	$19.8B	$20.9B	$22.4B	$22.2B	$21.2B	$21.2B
YoY change	+6.11%	+3.22%	+0.63%	-0.1%	-0.61%	+2.06%	-2.07%	+1.74%	+2.99%	+1.49%	+7.38%	+1.51%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	15.1B	11.8B	10.3B	16.2B	10.3B	7.2B	8.2B	9.5B	9.6B	9.9B
Receivables	4.6B	4.7B	5B	4.2B	4.7B	5.1B	5.5B	6.1B	6.2B	6.1B
Inventory	4.6B	4.7B	5B	5.5B	6B	6.9B	7.1B	7B	7.6B	8.2B
Total current assets	26.5B	23.3B	22.5B	28B	23.1B	21.7B	22.6B	24.7B	25.4B	26.2B
Property, plant & equipment	12.9B	13.4B	13.5B	13B	13.5B	13.1B	13.6B	13.6B	14.7B	15.6B
Goodwill & intangibles	137.8B	138.2B	129B	127.4B	129.1B	126.8B	128.9B	124.7B	127.1B	125.4B
Total assets	120.4B	118.3B	115.1B	120.7B	119.3B	117.2B	120.8B	122.4B	125.2B	126.5B
Accounts payable	9.6B	10.3B	11.3B	12.1B	13.7B	14.9B	14.6B	15.4B	15.2B	16.3B
Short-term debt	13.6B	10.4B	9.7B	11.4B	9.1B	8.8B	10.5B	7.4B	9.8B	11.5B
Total current liabilities	30.2B	28.2B	30B	33B	33.1B	33.1B	35.8B	33.6B	36.1B	38.7B
Long-term debt	18B	20.9B	20.4B	24.2B	23.7B	23.4B	25B	25.9B	25.7B	23.5B
Total liabilities	64.6B	65.4B	67.5B	73.8B	72.7B	70.4B	73.8B	71.8B	72.9B	72.2B
Shareholders' equity	55.8B	52.9B	47.6B	46.9B	46.7B	46.9B	47.1B	50.6B	52.3B	54.3B
Total debt	31.6B	31.3B	30.1B	35.6B	32.8B	32.3B	35.4B	33.4B	35.5B	35B
Net debt	26B	28.7B	25.9B	19.4B	22.6B	25.1B	27.2B	23.9B	25.9B	25.1B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Cash & short-term investments	9.7B	7.9B	6.8B	—	12.2B	10.2B	9.1B	—	11.2B	10.8B	12.3B	9.9B
Receivables	6.2B	6.3B	6.1B	—	6.3B	6.2B	6.1B	—	6.5B	6.3B	6.3B	6.1B
Inventory	7.1B	7.2B	7.1B	—	7.3B	7B	7.4B	—	7.8B	7.8B	7.9B	8.2B
Total current assets	24.9B	23.1B	22.5B	—	27.4B	25.6B	24.4B	—	27.1B	26.6B	28B	26.2B
Property, plant & equipment	—	—	—	37.5B	—	—	—	40.1B	—	—	—	15.6B
Goodwill & intangibles	127.8B	126.4B	125.5B	—	126B	123.5B	124.6B	—	126.9B	126.8B	125.8B	125.4B
Total assets	122.5B	120.7B	119.6B	—	126.5B	122.6B	123B	—	127.6B	127.3B	128.4B	126.5B
Accounts payable	14.4B	14.2B	13.7B	—	15.3B	14.5B	14.5B	—	15.6B	15.2B	15B	16.3B
Short-term debt	11.8B	10.6B	7.7B	—	10.4B	9.4B	9.9B	—	11.6B	11.1B	13.2B	11.5B
Total current liabilities	37.2B	36B	32.3B	—	36.4B	33.8B	34.2B	—	38B	36.7B	38.2B	38.7B
Long-term debt	24.1B	23.1B	24.3B	—	25.7B	25.3B	24.3B	—	24.3B	25.6B	23.9B	23.5B
Total liabilities	74.5B	71.9B	69.3B	—	74.3B	71.2B	70.4B	—	74B	74B	73.6B	72.2B
Shareholders' equity	48B	48.8B	50.3B	—	52.1B	51.4B	52.5B	—	53.6B	53.3B	54.7B	54.3B
Total debt	35.9B	33.7B	32B	—	36.2B	34.7B	34.1B	—	35.9B	36.6B	37B	35B
Net debt	26.1B	25.8B	25.2B	—	24B	24.5B	25B	—	24.8B	25.8B	24.7B	25.1B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	15.4B	9.9B	4B	13.1B	14.4B	14.8B	14.7B	15B	16.1B	16.1B
Depreciation & amortization	2.8B	2.8B	2.8B	3B	2.7B	2.8B	2.7B	2.9B	2.8B	3.2B
Stock-based compensation	351M	395M	515M	558M	540M	528M	545M	562M	476M	524M
Change in working capital	-443M	3B	368M	1.2B	371M	-1.1B	-1.2B	-436M	-821M	362M
Operating cash flow	17.7B	14.7B	7.6B	17.4B	17.9B	16.8B	16.9B	18.7B	17.1B	19.6B
Capital expenditure	—	—	—	—	—	—	—	—	—	-4.4B
Investing cash flow	-3.3B	206M	-143M	6.1B	-102M	-1.3B	-438M	-182M	-45M	-4.6B
Dividends paid	-7.2B	-7.3B	-7.5B	-7.8B	-8.3B	-8.8B	-9B	-9.3B	-9.9B	-10.2B
Share repurchases	-5.2B	-7B	-5B	-7.4B	-11B	-10B	-7.4B	-5B	-6.5B	-5B
Financing cash flow	-11B	-15.6B	-13.3B	-23.3B	-34.2B	-28.4B	-29.8B	-24.4B	-23.4B	-25.4B
Net change in cash	3.4B	-649M	-5.9B	185M	-16.4B	-12.8B	-13.3B	-5.9B	-6.4B	-10.4B
Free cash flow	9.4B	11.2B	11.9B	14.3B	15.6B	13.6B	13.8B	16.5B	14B	15.1B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Net income	4.6B	3.5B	3.8B	3.1B	4B	4.7B	3.8B	3.6B	4.8B	4.3B	4B	3.1B
Depreciation & amortization	702M	721M	712M	761M	728M	706M	690M	723M	761M	802M	785M	812M
Stock-based compensation	125M	150M	158M	129M	105M	136M	123M	112M	121M	141M	132M	130M
Change in working capital	-786M	-487M	-606M	1.4B	-1.5B	-1.5B	-1.8B	1.3B	40M	-148M	-228M	698M
Operating cash flow	4.9B	3.8B	4.1B	5.9B	3.5B	5.4B	4.5B	3.9B	5.4B	5B	4B	5.1B
Capital expenditure	—	—	—	—	—	—	—	—	-1.2B	-1.2B	-1B	-1B
Investing cash flow	-297M	-185M	35M	265M	-115M	4M	133M	-67M	-1.5B	-1.2B	-665M	-1.2B
Dividends paid	-2.3B	-2.3B	-2.3B	-2.4B	-2.4B	-2.4B	-2.4B	-2.6B	-2.5B	-2.5B	-2.5B	-2.6B
Share repurchases	-1.5B	-1B	-987M	-1.5B	-1.9B	-2.5B	-1.4B	-700M	-1.3B	-2.3B	-625M	-875M
Financing cash flow	-4.3B	-10.3B	-6.5B	-3.6B	-2.4B	-9.1B	-5.9B	-7B	-4.2B	-8.8B	-5.1B	-10B
Net change in cash	354M	-6.8B	-2.3B	2.6B	999M	-3.7B	-1.3B	-3.2B	-300M	-5B	-1.7B	-6B
Free cash flow	4B	4.3B	3.3B	5B	3.3B	3.9B	2.8B	4B	4.2B	3.8B	3B	4.1B

Date	Ratio
Jun 21, 2004	2:1
Sep 22, 1997	2:1
Jun 15, 1992	2:1
Nov 20, 1989	2:1
Feb 22, 1983	2:1
May 19, 1970	2:1

The Procter & Gamble Company Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history